GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nevro Corp (NYSE:NVRO) » Definitions » Shiller PE Ratio

Nevro (NVRO) Shiller PE Ratio : (As of Jun. 02, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Nevro Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Nevro Shiller PE Ratio Historical Data

The historical data trend for Nevro's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nevro Shiller PE Ratio Chart

Nevro Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nevro Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nevro's Shiller PE Ratio

For the Medical Devices subindustry, Nevro's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nevro's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nevro's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nevro's Shiller PE Ratio falls into.



Nevro Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Nevro's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Nevro's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.7/131.7762*131.7762
=-0.700

Current CPI (Mar. 2024) = 131.7762.

Nevro Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -10.993 100.560 -14.406
201409 -0.337 100.428 -0.442
201412 -0.590 99.070 -0.785
201503 -0.570 99.621 -0.754
201506 -0.770 100.684 -1.008
201509 -0.700 100.392 -0.919
201512 -0.510 99.792 -0.673
201603 -0.330 100.470 -0.433
201606 -0.310 101.688 -0.402
201609 -0.140 101.861 -0.181
201612 -0.340 101.863 -0.440
201703 -0.500 102.862 -0.641
201706 -0.400 103.349 -0.510
201709 -0.210 104.136 -0.266
201712 -0.150 104.011 -0.190
201803 -0.590 105.290 -0.738
201806 -0.350 106.317 -0.434
201809 -0.370 106.507 -0.458
201812 -0.320 105.998 -0.398
201903 -1.450 107.251 -1.782
201906 -0.910 108.070 -1.110
201909 -0.580 108.329 -0.706
201912 -0.440 108.420 -0.535
202003 -0.780 108.902 -0.944
202006 -1.210 108.767 -1.466
202009 -0.290 109.815 -0.348
202012 -0.210 109.897 -0.252
202103 -0.850 111.754 -1.002
202106 -0.620 114.631 -0.713
202109 -1.440 115.734 -1.640
202112 -0.860 117.630 -0.963
202203 -0.980 121.301 -1.065
202206 -0.710 125.017 -0.748
202209 2.220 125.227 2.336
202212 -0.540 125.222 -0.568
202303 -0.980 127.348 -1.014
202306 -0.690 128.729 -0.706
202309 -0.650 129.860 -0.660
202312 -0.250 129.419 -0.255
202403 -0.700 131.776 -0.700

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nevro  (NYSE:NVRO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Nevro Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Nevro's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nevro (NVRO) Business Description

Traded in Other Exchanges
Address
1800 Bridge Parkway, Redwood City, CA, USA, 94065
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
Executives
Greg Siller officer: Chief Commercial Officer C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY CA 94065
Shawn Mccormick director 9600-54TH AVENUE NORTH, SUITE 100, PLYMOUTH MN 55441
Kevin R Thornal officer: President & CEO 250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Sridhar Kosaraju director 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Elizabeth H Weatherman director C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Richard B. Carter officer: Chief Accounting Officer C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY CA 94065
Kashif Rashid officer: General Counsel C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY CA 94065
D Keith Grossman director, officer: President & CEO
Kevin C Oboyle director 5964 LA PLACE COURT, CARLSBAD CA 92008
Michael F Demane director, officer: Chief Executive Officer MEDTRONIC INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604
Niamh Louise Pellegrini officer: Chief Commercial Officer C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY CA 94065
Brad Vale director C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY CA 94065
Susan E Siegel director 3000 SAND HILL ROAD, BLDG 3 STE 290, MENLO PARK CA 94025
Roderick H. Macleod officer: Chief Financial Officer C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY CA 94065
Patrick Schmitz officer: Vice President, Operations C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY CA 94065